- Successful and Rapid Reduction in Neurosedative and Analgesic Medications in Complex Infants with Severe Bronchopulmonary Dysplasia After Tracheostomy Placement: Experience with 24-hour Propofol Infusions
Kathleen E. Hannan et al, 2024, The Journal of Pediatrics CrossRef - Propofol in the Pediatric Intensive Care Unit, a Safe and Effective Agent in Reducing Pain and Sedation Infusions: A Single-Center Retrospective Study
Sruti Uppuluri et al, 2022, Cureus CrossRef - MicroRNA-17-5p Protects against Propofol Anesthesia-Induced Neurotoxicity and Autophagy Impairment via Targeting BCL2L11
Mingyu Xiu et al, 2022, Computational and Mathematical Methods in Medicine CrossRef - Changes in Rat Brain MicroRNA Expression Profiles Following Sevoflurane and Propofol Anesthesia
Yu Lu et al, 2015, Chinese Medical Journal CrossRef - Chitosan Oligosaccharide Reduces Propofol Requirements and Propofol-Related Side Effects
Zhiwen Li et al, 2016, Marine Drugs CrossRef